Navigation Links
Hospital Acquired Infection Control Market: Sterilization, Disinfection, Testing and Treatment
Date:9/5/2013

DALLAS, Sept. 5, 2013 /PRNewswire-iReach/ -- This report focuses on preventing, testing and treating hospital-acquired infections in the healthcare environment. The major consideration is given to bacterial nosocomial infections because a) they are the most frequent type of infections spread in the health care delivery setting, and b) the practical aspects of diagnosis and therapy are more meaningful based on a combination of medical and financial considerations. Given the cost of hospital-acquired and healthcare-associated infections (HAIs), demand has increased for solutions that can help the healthcare industry reduce infections and the costs associated with them. The U.S. Centers for Disease Control and Prevention (CDC) estimates that around 1 in 20 or 5% of hospitalized patients will contract an HAI. Worldwide, the rate of nosocomial infections is between 3.5% and 12% of admissions in developed regions. This has created a market opportunity for companies that can test for, treat and help prevent these infections. This opportunity is detailed in Kalorama Information's report, The Market for Hospital-Acquired Infection Control (Sterilization, Cleaning, Testing, Treatment) available at http://www.rnrmarketresearch.com/the-market-for-hospital-acquired-infection-control-sterilization-disinfection-testing-and-treatment-market-report.html .

(Photo: http://photos.prnewswire.com/prnh/20130905/MN74807)

The majority of competitive participation for Hospital-Acquired Infection control is in the United States and Europe. However, competition is steadily escalating in the United States and Europe, which is encouraging more participation in other areas such as Asia and Latin America. Companies in this report include: Advanced Sterilization Products, Becton Dickinson, Belimed AG, bioMerieux, Cantel, Cepheid, Kimberly-Clark, Merck & Co., Nordion, Pfizer, Roche, Steris and TSO3. In looking at infections in the health environment, we consider the diagnostic and therapeutic technologies that are currently available and attempt to project trends for preventing, detecting and treating these infections. To some extent, we are limited by the activity of the industries associated with the activities mentioned above for these infections. For the most part, these activities are limited and the advanced technologies seen in other areas of medical application are not necessarily present in terms of microbiology.

Table of Contents for the report The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) available for purchase at http://www.rnrmarketresearch.com/contacts/purchase?rname=113083  includes.

CHAPTER ONE: EXECUTIVE SUMMARY

Overview

The Nosocomial Infection

Scope and Methodology

Total Size and Growth of the Market

Issues and Trends Affecting Market

Leading Competitors

CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS

Overview

Introduction to Pathogens

Classification of Antibacterial Organisms

Patient Risk Factors

General Infection Statistics

Populations at Risk for Infection

Demographics of the World

Life Expectancy

Nosocomial Infection Statistics

Common Hospital (nosocomial) Infections

Description of Infections

Infection Risk Assessments by Hospital Department

Burn Units

Intensive Care Units

Emergency Departments

Hospital Length of Stay

Extended Stay Environments

International Trends in Nursing Facilities

Economic Trends

Comparison Between Healthcare Spending and Real Health Outcomes

U.S. Government's National Plan to Prevent Healthcare Associated Infections (HAIs)

Steering Committee

The American Recovery and Reinvestment Act of 2009

Affordable Care Act (ACA) Funding

Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Funding

U.S. Statewide Standardized Infection Ratio

Reduction in Hospital Acquired Infections

Reduction in Infections in Israel

Burden of Hospital Acquired Infections

Hospital-Acquired Infection Surveillance Process

Case Studies

Arizona Prevention Study

Connecticut Funding for HAI Prevention and Reporting

Pennsylvania Study of HAI Admissions and Readmissions

Infections and Drug Resistance

Easing Approvals of Antibiotics

Causes of Drug Resistance

Antibiotic Abuse

Antibiotic Use in Agriculture

Drug Resistance in Select Populations

Children

The Elderly

Compromised Individuals

Measures for Reducing Resistance

Testing for the Selection of Anti-bacterial Therapy

Monitoring Therapy

Screening Hospitalized patients

Pharmaceutical Manufacturer and Marketer Trends

Trends in Partnerships and Alliances

Developers Trends

CHAPTER THREE: INFECTION PREVENTION

Overview

Methods of Transmission

Airborne

Contact

Droplet

Vehicle

High-Risk Facilities or Departments

Technology Overview

Potential Use of Copper for Reducing Infections

Wide Area Disinfection Methods

Software for Infection Detection and Control

Antiseptic-Coated Catheters

Sterilization vs. Disinfection

Sterilization

Disinfection

Equipment and Solutions

Heat/Steam Sterilization

Developments

Chemical Sterilization

Sterilants

Developments

Radiation Sterilization

Developments

Market Overview

Hospital-Acquired Infection Prevention Market by Geographical Region

Competitive Analysis

CHAPTER FOUR: INFECTION TESTING

Overview

Drug-Resistance/Susceptibility Testing

Genotypic Methods

DNA Sequencing

Solid-phase Hybridization Techniques

Microarrays

Real-time Polymerase Chain Reaction Techniques

Phenotypic Methods

Phage-based Assays

Colorimetric Methods

The Nitrate Reductase Assay

Specific Serious Hospital-Acquired Infection Testing

Acinetobacter Baumannii

Clostridium Difficile

Developments

Hospital-Acquired Pneumonia

Pseudomonas Aeruginosa

Staphylococcus Aureus

Methicillin-resistant Staphylococcus Aureus (MRSA)

Vancomycin-Intermediate/Resistant Staphylococcus Aureus (VISA/VRSA)

Developments

Tuberculosis

Developments

Urinary Tract Infections

Vancomycin-resistant Enterococcus

Developments

Ventilator-Associated Pneumonia

New Developments

Market Overview

Total Market Size and Forecast

Hospital-Acquired Infection Testing Market by Geographical Region

Competitive Analysis

CHAPTER FIVE: INFECTION TREATMENT

Overview

Principles of Anti-bacterial Therapy

Infecting Organism

Antibiotic Sensitivity Testing

Site of Infection

Host Defenses and Organ Function

Antibiotic Pharmacokinetics

Monitoring Therapy

Classifications of Antibacterial Products

Carbapenems

Cephalosporins

Macrolides

Penicillins

Quinolones

Sulfonamides

Tetracyclines

Treatment Guidelines

Clostridium Difficile

Gastroenteritis

Hospital-Acquired Pneumonia

Ventilator-associated Pneumonia

Pseudomonas Aeruginosa

Staphylococcus Aureus

Stenotrophomonas maltophilia

Tuberculosis

Urinary Tract Infections

Leading Products

New Developments

Total Market Size and Forecast

Hospital-Acquired Infection Treatment Market by Geographical Region

Competitive Analysis

CHAPTER SIX: MARKET OPPORTUNITIES FOR HOSPITAL-ACQUIRED INFECTION CONTROL

Market Considerations

Market Overview

Hospital-Acquired Infection Control Market by Geographical Region

CHAPTER SEVEN: COMPANY PROFILES

Introduction

Advanced Sterilization Products

Company Performance

Becton, Dickinson

Company Performance

Belimed

Company Performance

bioMerieux

Company Performance

Cantel

Company Performance

Cepheid

Company Performance

Getinge Group

Company Performance

Kimberly-Clark

Company Performance

Merck & Co

Company Performance

Nordion

Company Performance

Pfizer

Company Performance

Roche

Company Performance

Sakura Seiki

Steris

Company Performance

Tso3

Company Performance

LIST OF MAJOR PROVIDERS

Explore more reports on Infectious Diseases Therapeutics market at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/infectious-diseases-therapeutics and other reports by Kalorama Information at http://www.rnrmarketresearch.com/publisher/Kalorama-Information.html .

About Us:

RnRMarketResearch.com ( http://www.rnrmarketresearch.com/ ) is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. Call +1 888 391 5441 with your research requirements. 

Media Contact: Priyank Tiwari, RnR Market Research, +1 888 391 5441, sales@rnrmarketresearch.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE RnR Market Research
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Chesapeake Urologys Dr. Brad Lerner, Chief of Urology at Union Memorial Hospital, Honored with Governors Citation for Outstanding Service
2. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
3. National Jewish Health, the Nations Premier Respiratory Hospital, Announces Lung Cancer Screening Trial Using Blood Test and CT
4. Without Environmental Hygiene, Hand Hygiene Programs Fall Short in Reducing HAIs in Hospital Settings, Says UMF Corporation
5. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
6. Physician-Patient Alliance for Health & Safety: Monitoring Technology for PCA Pumps Can Prevent Adverse Events: So Why Are Hospitals Not Using It?
7. Failure to Take Medicine Linked to Unnecessary Hospital Visits, Especially for Medicare Patients Taking High Blood Pressure or High Cholesterol Medications
8. Student of Liver And Vascular Surgery of West China Hospital of Sichuan University Addresses The 18th ILTS Annual Meeting in the United States
9. Hospitals Gain Time and Money Maximizing Distributor Value
10. Greenville Hospital System Achieves Dramatic Improvement in Hand Hygiene Compliance Rates Using New Technology from DebMed®
11. Hospitals Across the Country Select Prognosis HIS Enterprise Clinical and Financial System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Dec. 5, 2016   Mallinckrodt Pharmaceuticals (NYSE: ... company, today announced that it received a perfect score ... (CEI), a national benchmarking survey and report on corporate ... transgender (LGBT) workplace equality, administered by the Human Rights ... major U.S. businesses which also earned top marks this ...
(Date:12/5/2016)... , Dec. 5, 2016 Special purpose needles are ... such as fluid and cells from organs or lumps and ... and sizes. The global market for special purpose needles is ... In terms of revenue, the global special purpose needles market ... the forecast period (2016–2026) and is expected to be valued ...
(Date:12/5/2016)...   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... 2 clinical study of sotagliflozin, a dual SGLT1 and ... the leading global organization funding type 1 diabetes research. ... trial, which randomized a total of 87 patients, was ... dose of sotagliflozin compared to a placebo control in ...
Breaking Medicine Technology:
(Date:12/5/2016)... , ... December 05, 2016 , ... ... Plastic Surgery, is excited to announce the arrival of the newest Sciton laser ... with the ability to use tunable non-ablative and ablative wavelengths for exceptional results. ...
(Date:12/5/2016)... ... December 05, 2016 , ... SyncDog, Inc., the leading ... magazine, a leading online tech news platform connecting technology innovators with news, experience, ... explores the state of enterprise mobility security today, and how the SyncDog SentinelSecure™ ...
(Date:12/5/2016)... ... 05, 2016 , ... Worldwise ®, a leading consumer ... kathy ireland® Worldwide for five additional years, announced by Kevin Fick, Worldwise CEO. ... agreement three years ago to design and develop the kathy ireland® Loved Ones™ ...
(Date:12/5/2016)... ... December 05, 2016 , ... Physicians Education Resource®, ... International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma, on February ... are honored to have Amy E. Herman present at this year’s conference, her ...
(Date:12/5/2016)... , ... December 05, 2016 , ... BSI and Brenntag ... United States and Canada for distribution of their natural fruits and beverage ... is an exciting addition to our Life Sciences product portfolio,” said Steve Brauer, ...
Breaking Medicine News(10 mins):